Synchrony (SYF) director acquires 775 RSUs at $71.05 in Form 4
Kamila K. Chytil, a director of Synchrony Financial (SYF), reported on Form 4 that she acquired 775 restricted stock units (RSUs) on 09/30/2025 at a reported price of $71.05 per share-equivalent.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kamila K. Chytil, a director of Synchrony Financial (SYF), reported on Form 4 that she acquired 775 restricted stock units (RSUs) on 09/30/2025 at a reported price of $71.05 per share-equivalent. The filing states the RSUs will vest in full on 09/30/2026, and each RSU represents a contingent right to one share of common stock. Following the reported acquisition, the filing lists total beneficial ownership of 15,543 shares. The Form 4 was signed by an attorney-in-fact on 10/02/2025.
Positive
- Director acquired 775 RSUs, showing alignment with shareholders
- Post-transaction beneficial ownership reported as 15,543 shares, increasing transparency
Negative
- None.
Insights
Director acquired time‑vested RSUs, increasing reported beneficial ownership.
This report documents a grant-based acquisition of 775 RSUs that vest on 09/30/2026, which is a standard form of equity compensation for directors. The filing shows continued alignment of the director's interests with shareholders through equity ownership.
Because the RSUs are subject to a one-year vesting schedule, the transaction represents deferred compensation rather than an immediate sale or exercise; the shares are contingent until vesting.
Form 4 properly discloses the RSU grant, execution date, and post-transaction ownership.
The filing reports a 09/30/2025 transaction date, a reported price of $71.05, and post-transaction ownership of 15,543 shares, meeting disclosure elements required by Section 16. The signature by an attorney-in-fact on 10/02/2025 is included.
There are no disclosed sales, exercises, or dispositions in this filing; it records an acquisition of contingent stock units only.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 775 | $71.05 | $55K |
Footnotes (1)
- F1. Represents restricted stock units that will vest in full on September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the Synchrony (SYF) Form 4 filed by Kamila K. Chytil report?
When will the reported RSUs vest for the SYF director?
Does the Form 4 show any sales or dispositions by the director?
Who signed the Form 4 and when was it signed?
AI-generated analysis. How Rhea-AI works. Not financial advice.